{
    "initial_scores": {
        "ideological_tilt": 0,
        "immigration": 0,
        "executive_power": 0,
        "federalism": 0,
        "security_liberty": 0,
        "economic_regulation": 0,
        "social_inclusion": 0
    },
    "critique": "This document is a continuation of an existing advisory council related to drug policy. It primarily deals with administrative matters, specifically extending the council's duration and modifying the number of members. There is no indication of a strong ideological tilt, immigration stance, expansion of executive power, or shift in federalism. It doesn't directly address national security vs. civil liberties, economic regulation, or social inclusion. Therefore, most axes should be scored as neutral. The change in the number of members is unlikely to have a significant impact on any of the axes.",
    "revised_scores": {
        "ideological_tilt": 0,
        "immigration": 0,
        "executive_power": 0,
        "federalism": 0,
        "security_liberty": 0,
        "economic_regulation": 0,
        "social_inclusion": 0
    }
}